
Tacrolimus Suppliers & Bulk Manufacturers
Available Forms: Capsule
Available Strengths: IR:0.5 mg, 1 mg , 5 mg; ER: 0.5 mg, 1 mg, 3 mg, 5 mg
Reference Brands: US: Prograf IR, Astagraf XL; EU: Prograf,Advagraf(PR)
Category: Oncology Cancer Care
Tacrolimus is available in Capsule and strengths such as IR:0.5 mg, 1 mg , 5 mg; ER: 0.5 mg, 1 mg, 3 mg, 5 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Tacrolimus is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Tacrolimus can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Tacrolimus Capsules are essential immunosuppressants widely used in organ transplant patients to prevent rejection. Available in both immediate-release (Prograf) and extended-release forms (Astagraf XL, Envarsus), these capsules are offered in strengths of 0.5 mg, 1 mg, 3 mg, 4 mg, and 5 mg across the U.S. and EU markets. Tacrolimus effectively inhibits T-lymphocyte activation, making it a vital part of post-transplant care. With multiple dosing options, it supports individualized therapy. Suitable for B2B pharmaceutical distribution, Tacrolimus capsules are available in branded and generic forms, ensuring broad accessibility and cost-effective solutions for hospitals, clinics, and healthcare providers in Europe and the U.S.
Frequently Asked Questions
Related Products
Atezolizumab
Strength: 1200 mg/20 mL
Form: Intravenous infusion
Reference Brands: Tecentriq® (EU & US)
View DetailsDurvalumab
Strength: 120 mg/4 mL, 500 mg/10 mL
Form: Injection
Reference Brands: Imfinzi® (US & EU)
View DetailsSunitinib
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg
Form: Tablet
Reference Brands: Sutent® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers